Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118200) titled 'Clinical Value of Thyroid-Stimulating Hormone Receptor Autoantibodies in the Follow-up of Graves' Disease: A Research Study' on Feb. 3.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Shanghai General Hospital
Condition:
Graves' disease
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-07
Target Sample Size: Antithyroid drug treatment group (ATD group) and radioactive iodine treatment group (RAI group):800;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=300116
Published by HT Digital Content...